The congenital neutropenia syndromes are rare conditions caused by mutations in genes associated with various cell processes. While their clinical presentations may overlap, their natural histories vary. Accurate diagnosis of the genetic etiology of specific conditions is crucial for providing individually tailored management, as the different syndromes have different risk profiles for progression to bone […]
Thermo Fisher Scientific has introduced a groundbreaking solution for more precise blood genotyping in clinical research. The Applied Biosystems™ Axiom™ BloodGenomiX™ Array and Software offers a single, high-throughput assay capable of detecting most extended and rare blood groups, as well as tissue (HLA) and platelet (HPA) types.
Using ferritin as a biomarker for hemophagocytic lymphohistiocytosis can reduce delays in treatment due to negative or pending hemophagocytosis results
Beckman Coulter Diagnostics, a leader in clinical diagnostics, has extended the menu of DxI 9000 Immunoassay Analyzer assays. Recently, tests for Hepatitis B and C viruses – namely Access anti-HCV, Access HBsAg, and Access HBsAg Confirmatory assays – received CE marks.
ProBioGen, a global Contract Development & Manufacturing Organization (CDMO), is partnering with DIOSynVax to manufacture DIOS-HFVac3, a trivalent haemorrhagic fever (HF) vaccine that was developed in collaboration with Prof. Dr. Ralf Wagners team at the Institute of Medical Microbiology and Hygiene, University of Regensburg. The novel vaccine targets HF diseases caused by Ebola, Marburg, and […]
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
